GMTX logo

Gemini Therapeutics (GMTX) EBIT

Annual EBIT

-$69.71 M
-$35.70 M-104.97%

December 31, 2021


Summary


Performance

GMTX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGMTXprofitabilitymetrics:

Quarterly EBIT

-$3.24 M
+$3.81 M+54.05%

September 30, 2022


Summary


Performance

GMTX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGMTXprofitabilitymetrics:

TTM EBIT

-$43.18 M
+$15.21 M+26.05%

September 30, 2022


Summary


Performance

GMTX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGMTXprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

GMTX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-105.0%+82.5%+3.7%
3 y3 years-105.0%+66.3%-350.1%
5 y5 years-105.0%+66.3%-350.1%

GMTX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+448.1%at high+61.4%
5 y5-year+105.0%at low-145.3%+470.1%+350.1%+61.4%
alltimeall time+105.0%at low-145.3%+470.1%+350.1%+61.4%

Gemini Therapeutics EBIT History

DateAnnualQuarterlyTTM
Sep 2022
-
-$3.24 M(-54.0%)
-$43.18 M(-26.0%)
Jun 2022
-
-$7.04 M(-53.6%)
-$58.39 M(-13.7%)
Mar 2022
-
-$15.16 M(-14.5%)
-$67.68 M(-2.9%)
Dec 2021
-$69.71 M
-$17.74 M(-3.8%)
-$69.71 M(+55.5%)
Sep 2021
-
-$18.45 M(+13.0%)
-$44.83 M(+30.5%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$16.33 M(-5.1%)
-$34.34 M(+39.1%)
Mar 2021
-
-$17.20 M(-340.9%)
-$24.68 M(+44.5%)
Dec 2020
-$34.01 M
$7.14 M(-189.7%)
-$17.08 M(-29.5%)
Sep 2020
-
-$7.96 M(+19.4%)
-$24.21 M(+48.9%)
Jun 2020
-
-$6.67 M(-30.5%)
-$16.26 M(+69.5%)
Mar 2020
-
-$9.59 M
-$9.59 M

FAQ

  • What is Gemini Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Gemini Therapeutics?
  • What is Gemini Therapeutics annual EBIT year-on-year change?
  • What is Gemini Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Gemini Therapeutics?
  • What is Gemini Therapeutics quarterly EBIT year-on-year change?
  • What is Gemini Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Gemini Therapeutics?
  • What is Gemini Therapeutics TTM EBIT year-on-year change?

What is Gemini Therapeutics annual earnings before interest & taxes?

The current annual EBIT of GMTX is -$69.71 M

What is the all time high annual EBIT for Gemini Therapeutics?

Gemini Therapeutics all-time high annual earnings before interest & taxes is -$34.01 M

What is Gemini Therapeutics annual EBIT year-on-year change?

Over the past year, GMTX annual earnings before interest & taxes has changed by -$35.70 M (-104.97%)

What is Gemini Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of GMTX is -$3.24 M

What is the all time high quarterly EBIT for Gemini Therapeutics?

Gemini Therapeutics all-time high quarterly earnings before interest & taxes is $7.14 M

What is Gemini Therapeutics quarterly EBIT year-on-year change?

Over the past year, GMTX quarterly earnings before interest & taxes has changed by +$15.21 M (+82.46%)

What is Gemini Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of GMTX is -$43.18 M

What is the all time high TTM EBIT for Gemini Therapeutics?

Gemini Therapeutics all-time high TTM earnings before interest & taxes is -$9.59 M

What is Gemini Therapeutics TTM EBIT year-on-year change?

Over the past year, GMTX TTM earnings before interest & taxes has changed by +$1.65 M (+3.69%)